Financial Data and Key Metrics Changes - Consolidated fourth quarter 2025 revenue was $154.8 million, down from $163.3 million in the prior year, primarily due to softening customer demand [7][10] - Adjusted EBITDA for the fourth quarter was $2.3 million, compared to $0.9 million in the prior year, with adjusted EBITDA margins at 1.5%, up 90 basis points [8][9] - Net loss for the quarter was $6.4 million, or a loss of $0.19 per diluted share, compared to a net loss of $35 million, or a loss of $1.04 per diluted share in the prior year [9][10] - Free cash flow from continuing operations for the quarter was $8.7 million, compared to $0.8 million in the prior year [10] Business Line Data and Key Metrics Changes - Global Seating segment revenues decreased by 5.6% to $70.7 million, with adjusted operating income increasing to $1.8 million [13] - Global Electrical Systems segment revenues increased by 12.7% to $49.7 million, with adjusted operating income rising to $0.9 million [14] - Trim Systems and Components revenues decreased by 22.5% to $34.4 million, with an adjusted operating loss of $1.4 million [16] Market Data and Key Metrics Changes - The North American Class 8 truck market is experiencing a decline, impacting demand across several segments [4][16] - The construction market is expected to grow in the low single-digit percentage range, driven by lower interest rates and fiscal stimulus initiatives [18] Company Strategy and Development Direction - The company is focusing on operational efficiency improvements and has announced a new contract with Zoox for autonomous vehicle components, indicating a strategic shift towards electric and autonomous vehicle markets [5][19] - The company aims to grow its Global Electrical Systems segment by more than 10% in 2026, supported by new business wins [20] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about a 4% increase in Class 8 truck build volumes for 2026, with expectations of a rebound in 2028 [18] - The company anticipates a year of top-line growth with net sales guidance of $660 million to $700 million for 2026, reflecting nearly 5% growth over 2025 [21] Other Important Information - Free cash flow generation and debt paydown remain a focus for the company in 2026, with a target leverage ratio of 2x [21] - The company generated $33.7 million in free cash for the full year, up $21.5 million from the previous year [5][12] Q&A Session Summary Question: Can you provide more color on the two new key programs? - Management confirmed that both programs are ramping up as planned, with the Zoox program on track for volume production by the second quarter [25][26] Question: What is the outlook for the aftermarket business? - The aftermarket business is expected to grow, driven by improved operational efficiencies and promotional initiatives [32][36] Question: What are the assumptions behind the guidance range for Adjusted EBITDA? - The guidance range reflects the volatility in the Class 8 truck market and the expectation of improved operating leverage as volumes increase [81][84]

Financial Data and Key Metrics Changes - For Q4 2025, total revenue was $5.1 million, a significant increase from $0.3 million in Q4 2024, primarily driven by net YCANTH revenue of $3.7 million and $1.4 million from Torii collaboration revenue [24] - Full year 2025 total revenue reached $35.6 million, up 368% from $7.6 million in 2024, with net YCANTH revenue of $15.3 million and $20.3 million from Torii collaboration [25] - Gross product margins for 2025 were 85.7%, compared to 71.8% in the prior year [25] Business Line Data and Key Metrics Changes - YCANTH revenue grew by over 130% compared to 2024, with Q4 2025 revenue of $3.7 million, reflecting a 3.2% increase from Q3 2025 [5][9] - Dispensed applicator units for YCANTH grew to 51,196 in 2025, a 99% increase from 25,773 units in 2024 [11] - In Q4 2025, YCANTH's dispensed applicator units increased by 58% compared to Q4 2024, although there was a slight decrease of approximately 3% from Q3 2025 [10] Market Data and Key Metrics Changes - The company is expanding its market presence in Europe, with positive feedback from the European Medicines Agency regarding the marketing authorization application for YCANTH [15] - The common warts market is estimated to have over 20 million patients in the U.S., significantly larger than the molluscum market, which has about 6 million patients [76] Company Strategy and Development Direction - The company aims to establish YCANTH as the new standard of care for molluscum contagiosum and is executing a label expansion strategy for common warts [4][35] - The company has strengthened its financial position through a $50 million equity raise and eliminated outstanding debt, extending its cash runway into 2027 [22][33] - The company is advancing its clinical programs for common warts and basal cell carcinoma, with a focus on efficient trial designs and potential partnerships for commercialization [20][22] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the future, highlighting the transformation of the business in 2025 and the potential for significant growth in 2026 [4][35] - The management noted that the largest competitor in the molluscum market is "watchful waiting," indicating a strong opportunity for YCANTH [49] - The company is excited about the potential of VP-315 as a non-surgical immunotherapy for basal cell carcinoma, aiming to change treatment paradigms [79] Other Important Information - The company has made significant investments in its co-pay assistance program to improve patient access to YCANTH [9] - The company is actively exploring non-dilutive funding opportunities for its clinical programs [22] Q&A Session Summary Question: What initiatives do you have in mind to broaden the YCANTH launch? - Management is seeing early growth in the YcanthRx program and aims to simplify patient and physician acquisition of the product [39] Question: What kind of partnerships might you be looking into around expansion into the EU? - The company is exploring partnerships to bring YCANTH to patients in need and provide access to caregivers [46] Question: How much of the TAM or how many molluscum prescribers do you plan to target with this size team? - The focus will continue on pediatricians while refining targeting in dermatology, with an emphasis on both specialties [53] Question: Can you help us think about the seasonality curve for YCANTH? - Historically, Q1 is slower, but recent investments in marketing and sales are showing positive trends [68] Question: What is the estimated cost for the VP-315 phase 3 program? - The company is still assessing costs and aims to run the program as efficiently as possible [60]

Financial Data and Key Metrics Changes - Total revenues for 2025 were $180.5 million, a 12% year-over-year increase from $161 million in 2024 [5][17] - Adjusted EBITDA for 2025 was $42 million, reflecting a 23% increase compared to $34.1 million in 2024 [5][19] - Net income for 2025 was $20.2 million, or $0.35 per diluted share, a 40% increase from $14.5 million, or $0.25 per diluted share, in 2024 [19] - Cash and cash equivalents at year-end 2025 were $75.5 million, down from $78.4 million in December 2024 [19] Business Line Data and Key Metrics Changes - Sales of KedRAB increased to approximately $54 million in 2025, exceeding the contract minimum commitment [10] - GLASSIA contributed total revenue of $35 million, with growth in ex-U.S. markets and royalty income from Takeda [10] - Revenue from Cytogam declined due to increased usage of antivirals, but a comprehensive post-marketing research program is expected to support future growth [11][12] Market Data and Key Metrics Changes - The company anticipates growth in the distribution segment through the launch of additional biosimilars in Israeli markets and expansion into the MENA region [9][13] - The Canadian Blood Services awarded a $10 million-$14 million extension for the supply of various products, securing ongoing sales in the Canadian market [17] Company Strategy and Development Direction - The company focuses on expanding its commercial product portfolio and investing in the commercialization of FDA-approved specialty plasma-derived products [9] - Plans to ramp up plasma collection at new centers, aiming for significant revenue generation from normal source plasma sales starting in 2026 [14] - The company is pursuing M&A opportunities to enrich its product portfolio and generate synergies with existing operations [15][16] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's operational and financial performance, despite geopolitical challenges in the Middle East [4] - The company affirmed its 2026 guidance of $200 million-$205 million in revenues and $50 million-$53 million in adjusted EBITDA, representing growth from 2025 results [7][8] - Management emphasized the importance of Cytogam in organ transplant protection and the potential for increased utilization following ongoing clinical studies [24] Other Important Information - A dividend of $0.25 per share, totaling approximately $14.4 million, was declared, reinforcing confidence in business prospects and liquidity [6] - The company expects to launch two additional biosimilars in Israel in mid-2026, contributing to growth in the distribution business [13][32] Q&A Session Summary Question: Impact of antivirals on Cytogam market - Management noted no change in CMV management protocols but acknowledged increased access to antivirals affecting Cytogam usage [22][23] Question: M&A opportunities and dividend implications - Management confirmed that the dividend payment does not indicate a change in M&A opportunities, expressing optimism for securing transactions in 2026 [25] Question: Plasma collection growth margin benefits - Management expects growth margin benefits from proprietary plasma collection to start impacting gross profit in 2027 and beyond [26] Question: Ramp-up of plasma collection centers - Current ramp-up is at 30%-40%, with full capacity expected by the end of 2027 [31] Question: Timing of biosimilars launch - Two additional biosimilars are expected to launch around mid-2026, with sales ramping up based on market demand [32] Question: Dividend payment schedule - The entire dividend will be paid in the second quarter [40]

Financial Data and Key Metrics Changes - The fourth quarter TCE rates averaged $17,773 per day, a premium of 19% over the average published market rates for Panamax, Supramax, and Handysize vessels [11] - Adjusted EBITDA for the fourth quarter was approximately $29 million, an increase of about $5 million year-over-year, driven by a 25% increase in shipping days and an 11% increase in TCE earned [11][12] - Adjusted EBITDA margin improved to 17% in Q4 2025 from 13% in the prior year [11] - Reported GAAP net income for the fourth quarter was $11.9 million or $0.19 per diluted share [13] - Adjusted net income attributable to Pangaea during the quarter was $10.1 million or $0.16 per diluted share [14] Business Line Data and Key Metrics Changes - Total shipping days increased by 26% year-over-year, largely due to the integration of Handysize vessels acquired from SSI [5] - Vessel operating expenses increased by 94% year-over-year, primarily due to the acquisition of the SSI fleet [13] - Total charter hire expenses increased by 36% compared to Q4 2024, reflecting a year-over-year increase in market rates [12] Market Data and Key Metrics Changes - Near-term dry bulk fundamentals remain constructive, supported by the resumption of normal trade relations from the U.S. to China [8] - The company has booked 5,920 shipping days at a TCE of $14,917 per day for the start of 2026, indicating healthy demand [9] Company Strategy and Development Direction - The company is focused on maintaining a modern, efficient fleet aligned with customer needs and regulatory requirements [6] - Priorities include fleet renewal, organic growth, balance sheet strength, and shareholder returns [7] - Investments in integrated logistics platform and terminal operations are expected to enhance customer relationships and recurring revenue opportunities [5][16] Management's Comments on Operating Environment and Future Outlook - Management noted that the direct impact of geopolitical disruptions in the Middle East is virtually non-existent for the company [20] - Indirect impacts are felt through increased volatility in fuel prices and potential trade disruptions [21] - The company expects renewed geopolitical focus on the Arctic region to be a positive long-term tailwind [9] - Market sentiment remains positive with pricing holding at favorable levels as the company enters 2026 [10] Other Important Information - The company repurchased approximately 600,000 shares for roughly $3 million and paid approximately $16.3 million in dividends throughout 2025 [7][16] - The company entered 2026 with approximately $103 million in unrestricted cash, supported by strong operating cash flow [8] Q&A Session Summary Question: Have you been able to leverage your Handysize vessels to grow your onshore port and terminal business? - Management confirmed experiencing nice synergies between the Handysize fleet and existing Supramax fleet, handling cargos on several Handysize vessels [19] Question: Has the dry bulk sector and Pangaea been affected by recent events in the Middle East? - Management stated that direct exposure is non-existent, but indirect impacts are felt through oil price volatility and potential trade disruptions [20][21] Question: Can you talk about the impact of fuel prices and how you manage forward-looking bunker fuel prices? - Management explained that exposure to fuel prices is managed through bunker adjustment clauses in contracts and hedging with derivatives [26][27] Question: Can you quantify the potential impact of terminal and port expansions on 2026 numbers? - Management expects an incremental EBITDA of around $3 million for 2026 from new terminal operations [46] Question: Can you discuss the fleet renewal strategy and what's on the front for both buy and sell sides? - Management indicated that decisions to sell older vessels are based on age and that they are actively looking for new candidates to add to the fleet [49]

Financial Data and Key Metrics Changes - Consolidated adjusted net income reached PEN 136 million in Q4 2025, compared to PEN 36 million in the same quarter last year, with full-year adjusted net income more than tripling to PEN 336 million [9][10] - Consolidated revenue grew 6% year-over-year in Q4, while adjusted EBITDA declined 14% FX neutral, reflecting Mexico's underperformance and unfavorable comparisons in Colombia [10][19] - For the full year, revenue grew 4%, while EBITDA declined 3% [10][21] - Free cash flow grew 35% to PEN 582 million, and year-end cash position increased 42% to PEN 335 million [27][29] Business Line Data and Key Metrics Changes - Mexico's revenues declined 3% in Q4, but oncology revenues grew 35% compared to the previous quarter, indicating early recovery [11][12] - Peru's revenue increased 11% in Q4, driven by high complexity services and a record low medical loss ratio of 48.5% [16][17] - Colombia's revenue grew 6% in Q4, with a full-year increase of 4%, supported by higher ticket prices [18][19] Market Data and Key Metrics Changes - Capacity utilization in healthcare services decreased by 2.3 percentage points to 64%, particularly in Colombia [10] - Mexico's operations are stabilizing, with early signs of recovery in surgeries and oncology services [31][38] Company Strategy and Development Direction - The company is focusing on expanding its reach in Mexico, particularly among privately insured families, and aligning with physician groups [6][7] - Auna aims to enhance its operational scale in Peru and diversify its revenue streams in Colombia through risk-sharing contracts [8][18] - The company plans to continue investing in strategic growth initiatives, particularly in Mexico and Peru, while managing costs effectively [29][32] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the recovery of Mexico's operations, with expectations for improved volumes and margins in 2026 [31][39] - The company anticipates a 12% increase in adjusted EBITDA and revenue growth of 12% for 2026, supported by disciplined cost management [32][33] Other Important Information - Auna successfully refinanced $825 million in debt, improving its capital structure and reducing interest expenses [9][29] - The company is set to open the Centro Ambulatorio Trecca in 2028, which is expected to significantly contribute to its business in Peru [49][52] Q&A Session All Questions and Answers Question: Can you break down your guidance by region or business line? - Management indicated that Mexico's recovery is expected to drive improvements, but they are not providing specific guidance by country at this time [35][43] Question: What are the risks to your 2026 guidance? - Management highlighted the pace of volume recovery in Mexico and macroeconomic conditions as key variables, but expressed confidence in achieving guidance [40][41] Question: Can you provide updates on the Torre Trecca project? - Management confirmed that Torre Trecca will commence operations in the second semester of 2028 and is expected to represent about 25% of the business in Peru at maturity [51][52] Question: What is the expected CapEx for 2026 and beyond? - Management stated that CapEx for 2026 is expected to be approximately 4% of revenue, focusing on maintenance and IT investments [61][62] Question: How are you planning the ramp-up in occupancy in Mexico? - Management emphasized that occupancy and margins will be managed through a higher mix of complex services, with a clear plan for recovery in 2026 [83][85]

Financial Data and Key Metrics Changes - Consolidated adjusted net income reached PEN 136 million in Q4 2025, compared to PEN 36 million in the same quarter last year, with full-year adjusted net income more than tripling to PEN 336 million [9][22] - Consolidated revenue grew 6% at FX neutral in Q4, while adjusted EBITDA declined 14% FX neutral, reflecting Mexico's underperformance and an unfavorable year-over-year comparison in Colombia [10][19] - For the full year, revenue grew 4%, while EBITDA declined 3% [10][21] - Free cash flow grew 35% to PEN 582 million, and year-end cash position increased 42% to PEN 335 million [27][29] Business Line Data and Key Metrics Changes - Mexico's revenues declined 3% in Q4, but showed stabilization with unchanged revenues from the previous quarter [11][12] - Peru's revenue increased 11% during Q4, driven by growth in high complexity services and a record low medical loss ratio [16] - Colombia's revenue increased 6% for the quarter, with a full-year revenue increase of 4%, mainly driven by higher ticket prices [18] Market Data and Key Metrics Changes - Capacity utilization in healthcare services decreased 2.3 percentage points to 64%, particularly in Colombia [10] - In Mexico, out-of-pocket revenues increased to 12% of total revenues in December, reflecting early recovery stages [11] - The oncology medical loss ratio in Peru improved to a record low of 48.5% [16] Company Strategy and Development Direction - The company aims to recover growth levels in Mexico and expand its reach into larger segments of privately insured families [6][31] - Auna is focusing on diversifying away from intervened payers in Colombia and prioritizing cash flows through risk-sharing arrangements [31] - The company plans to continue investing in strategic growth initiatives, particularly in Mexico and Peru, with expected adjusted EBITDA growth of 12% FX neutral in 2026 [32] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the stability of the business and the outlook for 2026, citing improvements in Mexico's operations and strong performance in Peru [40][41] - The main risks to guidance include the pace of volume recovery in Mexico and macroeconomic conditions in operating markets [40] - Management highlighted the importance of maintaining a higher mix of services and specialties to improve margins in Mexico [84] Other Important Information - The company successfully refinanced $825 million in debt, improving its maturity profile and lowering interest expenses [9][29] - The extension of the healthcare plan with ISSSTE León is expected to result in a double-digit price increase for 2026 [49] - The Torre Trecca project is expected to commence operations in the second semester of 2028, representing a significant opportunity for Auna [52] Q&A Session Summary Question: Can you break down guidance by region or business line? - Management indicated that Mexico is expected to drive most of the improvement, but they are not providing guidance by country at this time [35][43] Question: What are the risks to your 2026 guidance? - Management noted that external factors such as political headwinds and operational challenges in Mexico were previously concerns, but they are now confident in the stability of the business [40] Question: Can you provide updates on the Torre Trecca project? - Management confirmed that Torre Trecca will commence operations in the second semester of 2028 and is expected to represent about 25% of the business in Peru at maturity [52] Question: What is the expected CapEx for 2026 and beyond? - Management stated that CapEx for 2026 is expected to be approximately 4% of revenue, focusing on maintenance investments and technology [61] Question: How is the board prioritizing capital allocation? - Management discussed the potential for share buybacks but emphasized that growth opportunities in Mexico would take priority [78]

Financial Data and Key Metrics Changes - Total net revenues for Q4 2025 reached RMB 6.25 billion, representing a 29% year-over-year growth [4][29] - For the full year 2025, total net revenues grew 28.9% year-over-year to RMB 21.05 billion, while non-GAAP operating profit reached RMB 560 million, up 35.5% year-over-year [5][30] - Non-GAAP operating profit for Q4 2025 was RMB 180 million, up 38.1% year-over-year [4][41] Business Line Data and Key Metrics Changes - Net product revenue in Q4 2025 increased by 30.7% to RMB 5.83 billion, driven by online sales of pre-owned consumer electronics [30] - The multi-category recycling business contributed nearly RMB 80 million in revenue for Q4 2025, accounting for 18.8% of service revenues [31] - In B2C, GMV from consignment increased by 253% year-over-year, accounting for 24% of total GMV of the Paipai marketplace business [17] Market Data and Key Metrics Changes - The overseas business has shown sequential growth for four consecutive quarters, with peak monthly revenue recently reaching RMB 50 million [11] - The total number of registered users on PJT Marketplace exceeded 101.66 million, growing both year-over-year and quarter-over-quarter [16] Company Strategy and Development Direction - The company aims to solidify its core second-hand consumer electronics business while optimizing user experience in recycling, fulfillment, and delivery [23] - AHS Recycle's brand marketing efforts are focused on strengthening brand awareness among consumers, particularly in luxury goods recycling [25] - The company plans to leverage its strengths in China to achieve strategic breakthroughs in international markets, enhancing industry efficiency [27] Management's Comments on Operating Environment and Future Outlook - The management views the 2026 market environment as net positive for the pre-owned industry, driven by rising new device prices and increased trade-in penetration [20][21] - The company expects total net revenue growth to continue outpacing the double-digit growth of the broader industry [52] Other Important Information - The company repurchased approximately 1.3 million ADS for about $5.8 million during Q4 2025 and announced a cash dividend of $0.1 per ADS for the fiscal year 2025 [42] - For Q1 2026, total revenues are anticipated to be between RMB 5,860 million and RMB 5,960 million, representing a year-over-year increase of 25.9%-28.1% [43] Q&A Session Summary Question: Impact of government subsidies and rising storage prices on the pre-owned consumer electronics industry - Management noted that the government has extended trade-in subsidies for various devices, which will benefit the pre-owned consumer electronics business in 2026 [48] - Rising new device prices create both opportunities and challenges, with trade-ins likely becoming a higher priority for e-commerce platforms [50] Question: Store opening targets for 2026 - The company plans to enhance store quality in high-tier cities and expand its store footprint in lower-tier cities, with a target of 5,000 stores remaining unchanged [59] Question: Improvement trajectory and margin expansion - Management highlighted that rising new device prices reinforce the commitment to the 1P retail strategy, expecting greater margin expansion as higher margin retail product revenue grows [62]

Financial Data and Key Metrics Changes - The fourth quarter TCE rates averaged $17,773 per day, a premium of 19% over the average published market rates for Panamax, Supramax, and Handysize vessels [11] - Adjusted EBITDA for the fourth quarter grew 22% year-over-year to approximately $29 million, driven by a 25% increase in shipping days and an 11% increase in TCE earned [5][11] - The adjusted EBITDA margin improved to 17% in Q4 2025 from 13% in the prior year [11] - Reported GAAP net income for the fourth quarter was $11.9 million or $0.19 per diluted share [13] - Total cash from operations was approximately $15 million, with unrestricted cash at approximately $103 million at quarter end [14] Business Line Data and Key Metrics Changes - Total shipping days increased by 26% year-over-year, largely due to the integration of Handysize vessels acquired from SSI [5] - Vessel operating expenses increased by 94% year-over-year, primarily due to the acquisition of the SSI fleet [13] - Total charter hire expenses rose by 36% compared to Q4 2024, reflecting increased market rates [12] Market Data and Key Metrics Changes - Near-term dry bulk fundamentals remain constructive, supported by the resumption of normal trade relations from the U.S. to China [8] - The company has booked 5,920 shipping days at a TCE of $14,917 per day for the start of 2026, indicating healthy demand [9] Company Strategy and Development Direction - The company is focused on maintaining a modern, efficient fleet aligned with customer needs and regulatory requirements [6] - Priorities include fleet renewal, organic growth, balance sheet strength, and shareholder returns [7][16] - Investments in integrated logistics platforms and terminal operations are expected to enhance customer relationships and recurring revenue opportunities [5][16] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's ability to generate consistent value for customers and shareholders, entering 2026 with strong operating momentum [10] - The geopolitical situation in the Middle East has had no direct impact on the company, but there may be indirect effects through increased volatility in fuel prices [20][21] - The company anticipates a positive long-term outlook due to renewed focus on the Arctic region [9] Other Important Information - The company repurchased approximately 600,000 shares for roughly $3 million and paid approximately $16.3 million in dividends throughout 2025 [7][16] - The company expects to see an incremental EBITDA of around $3 million in 2026 from new terminal operations [46] Q&A Session Summary Question: Have you been able to leverage your Handysize vessels to grow your onshore port and terminal business? - Management confirmed experiencing nice synergies between the Handysize fleet and existing Supramax fleet, handling cargos on several Handysize vessels [19] Question: Has the dry bulk sector and Pangaea been affected by recent events in the Middle East? - Management stated that direct exposure to the conflict is virtually non-existent, but indirect impacts may be felt through oil price volatility and potential trade disruptions [20][21] Question: Can you talk about the impact of fuel prices and how you manage your exposure? - Management explained that exposure to fuel prices is managed through bunker adjustment clauses in contracts and hedging with derivatives for short-term exposure [26][27] Question: What is the potential impact of the terminal expansion on 2026 numbers? - Management expects a step-up in incremental EBITDA of around $3 million for 2026 as new terminals come online [46] Question: Can you discuss the fleet renewal strategy? - Management indicated that decisions to sell older vessels are based on age and that they are actively looking for new candidates to add to the fleet [49]

Financial Data and Key Metrics Changes - Acacia reported total revenue of $285.2 million for 2025, a record for the company, representing a 133% increase year-over-year from $122.3 million in 2024 [35] - Total Adjusted EBITDA for 2025 was $77.9 million, with operated segment Adjusted EBITDA reaching $96.4 million [24][35] - The company recorded a GAAP net income of $21.7 million or $0.22 per diluted share for 2025, compared to a net loss of $36.1 million or negative $0.36 per diluted share in the prior year [38] Business Line Data and Key Metrics Changes - Energy operations generated $63.8 million in revenue for 2025, up from $49.2 million in 2024, reflecting a full year of results from the acquisition of Revolution assets [35] - Manufacturing operations generated $114.8 million in revenue for the year, while industrial operations generated $28.3 million, down from $30.4 million in the previous year [35] - Intellectual property operations generated $78.4 million in licensing and other revenue for 2025, compared to $19.5 million in 2024 [35] Market Data and Key Metrics Changes - The Class 8 trucking market has shown signs of recovery, with orders increasing year-over-year by 23%, 25%, and 156% in the last three months of the year [14] - The Canadian housing market has faced building cost pressures and a slowdown in home sales, impacting the air distribution segment [15][16] Company Strategy and Development Direction - The company aims to build a portfolio of operating companies that create long-term compounding value while preserving capital [6] - Acacia is focused on managing expenses and capital allocation prudently, with plans to continue acquiring valuable operating businesses at attractive prices [7][11] - The management is optimistic about the potential for growth in 2026, leveraging operational improvements and market opportunities [43] Management's Comments on Operating Environment and Future Outlook - Management acknowledged ongoing macroeconomic challenges, including inflation and tariff-related headwinds, but expressed confidence in the company's ability to navigate these issues [10] - The management believes that the fundamentals of the business and the inherent value of assets are strong and continue to improve [25] Other Important Information - The company maintained a cash position of approximately $340 million at the end of 2025, down from $350 million at the end of 2022 [8] - Acacia's total indebtedness was $92.1 million as of December 31, 2025, with no parent company debt [41] Q&A Session Summary Question: Expectations for the new well in Cherokee - Management indicated that it is difficult to compare the new well to existing Benchmark wells but expressed optimism about its production potential [48] Question: Plans for Cherokee assets - Management stated that selling the Cherokee assets is an option but emphasized evaluating all opportunities as activity develops in the basin [50] Question: Average hedge price per barrel - The average hedge price is approximately $70 per barrel, with plans to continue hedging new volumes from the new well [51] Question: Operating margins and EBITDA aspirations for Deflecto - Management is optimistic about operational improvements and anticipates benefiting from cyclical rebounds in the market [60] Question: Sale of the floor mat business - The decision to sell was based on strategic considerations, as the business was deemed subscale [63] Question: Impact of AI on the legacy patent portfolio - Management believes AI could serve as a tailwind for the value of the legacy patent portfolio, primarily focused on Wi-Fi 6 [64] Question: Thoughts on private equity market conditions - Management noted that while good assets are still not moving, there are opportunities in the B and C quartile assets [80] Question: Capital allocation and buyback considerations - Management is continuously evaluating capital allocation options, including potential buybacks, but has not made any announcements yet [92]

Financial Data and Key Metrics Changes - Acacia reported total revenue of $285.2 million for 2025, a 133% increase year-over-year from $122.3 million in 2024 [35] - Total Adjusted EBITDA for 2025 was $77.9 million, with operating cash flow of $75.2 million, both higher year-over-year [10][24] - The company recorded a GAAP net income of $21.7 million or $0.22 per diluted share in 2025, compared to a net loss of $36.1 million or negative $0.36 per diluted share in the prior year [38] Business Line Data and Key Metrics Changes - Energy operations generated $63.8 million in revenue for 2025, up from $49.2 million last year, reflecting a full year of results from the acquisition of Revolution assets [35] - Manufacturing operations generated $114.8 million in revenue for the year, while industrial operations generated $28.3 million, down from $30.4 million last year [35] - Intellectual property operations generated $78.4 million in licensing and other revenue for the year, compared to $19.5 million last year [35] Market Data and Key Metrics Changes - The Class 8 trucking market showed signs of recovery, with orders improving year-over-year by 23%, 25%, and 156% in the last three months of the year [14] - The Canadian housing market faced building cost pressures and a slowdown in sales velocity, impacting the air distribution segment [15] Company Strategy and Development Direction - The company aims to build a portfolio of operating companies that create long-term compounding value while preserving capital [6] - Acacia is focused on managing expenses and capital allocation prudently while exploring acquisition opportunities in the current market environment [25][66] - The strategy includes leveraging strong cash generation to pay down debt and enhance operational efficiencies across its segments [11][19] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in navigating macroeconomic challenges and highlighted the importance of operational improvements and strategic acquisitions [10][25] - The company remains optimistic about the potential for growth in 2026, driven by a robust pipeline of opportunities and ongoing improvements in operational performance [43] Other Important Information - The company maintained a strong balance sheet with cash and cash equivalents totaling $339.6 million at the end of 2025, up from $297 million at the end of 2024 [39] - Acacia's total indebtedness was $92.1 million as of December 31, 2025, with no parent company debt [41] Q&A Session Summary Question: Expectations for the new well in Cherokee - Management indicated that the new well is expected to produce better results than existing wells, with several attractive locations identified for future drilling [48][49] Question: Thoughts on selling Cherokee assets - Management acknowledged that selling the Cherokee assets is an option, but they will evaluate the production potential before making any decisions [50] Question: Average hedge price per barrel - The average hedge price is currently about $70 per barrel, with plans to continue hedging new production from the recently drilled well [51] Question: Operating margins and EBITDA aspirations for Deflecto - Management is optimistic about operational improvements and anticipates benefits from cost-saving initiatives and market recovery [60][61] Question: Rationale behind selling the floor mat business - The floor mat business was deemed subscale, and the sale was considered a strategic capital allocation decision [63] Question: Impact of AI on the legacy patent portfolio - Management believes that AI could serve as a tailwind for the value of the legacy patent portfolio, particularly in connectivity [64] Question: Current state of private equity and credit markets - Management noted that while there are opportunities in the private equity market, it is not yet a buyer's market for good assets [80] Question: Capital allocation and potential buyback - Management is continuously evaluating capital allocation options, including the potential for share buybacks when appropriate [92][94]